☆ 4.2 Letter

Fulminant hepatitis as an immune-related adverse event after nivolumab treatment

PATHOLOGY INTERNATIONAL (2019)

Get Full Text
Add to Collection

Journal

PATHOLOGY INTERNATIONAL
Volume 69, Issue 7, Pages 434-436

Publisher

WILEY
DOI: 10.1111/pin.12812

Keywords

fulminant hepatitis; immune-related adverse event; nivolumab; treatment

Categories

Pathology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.